Riad Mishlawi
CEO at HIKMA PHARMACEUTICALS INC
Manager
Deal Bio
Expertise (2)
Key Relationships
Sort
CUSTOPHARM
Hikma Pharmaceuticals
£310m
10 dealmakers
Xellia Pharmaceuticals (us Finished Dosage Form Business)
£145m
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.